Mithra Pharmaceuticals S.A.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MITPF research report →
Price Chart
About the company
Mithra Pharmaceuticals SA, established in 1999 and headquartered in Liège, Belgium, specializes in the creation, production, and worldwide commercialization of advanced therapeutic solutions. The company's core focus areas include contraception, the management of menopause, and treatments for hormone-dependent cancers. Its robust development pipeline features Estelle, a combined oral contraceptive that has successfully concluded Phase III clinical trials, and Donesta, an estetrol-based oral hormone treatment currently undergoing Phase III development for menopausal symptoms.
- CEO
- Christophe Marechal
- IPO
- 2020
- Employees
- 270
- HQ
- Liège, BE
Get TickerSpark's AI analysis on MITPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $1.60B
- P/E
- -0.09
- Fwd P/E
- 38.60
- PEG
- -0.00
- P/S
- 0.36
- P/B
- -0.14
- EV/EBITDA
- -4.00
- Div Yield
- 0.00%
- Gross Margin
- 14.92%
- Op Margin
- -172.63%
- Net Margin
- -432.08%
- ROE
- 498.80%
- ROIC
- -32.14%
Latest fiscal year · YoY change
- Revenue
- $40.16M-40.1%
- Gross Profit
- $5.99M-83.1%
- Op Income
- $-69,321,000
- Net Income
- $-173,502,000-191.0%
- EPS
- $-2.51-105.7%
- OCF Growth
- +96.7%
- FCF Growth
- +97.6%
- 52W High
- $23.90
- 52W Low
- $6.75
- 50D MA
- $6.75
- 200D MA
- $6.75
- Beta
- 0.60
- RSI (14)
- 100
- Avg Volume
- 285
No earnings-call transcripts are available for MITPF yet.
- Free Float
- 97.6%
- Shares Outstanding
- 66.91M
- Float Shares
- 65.32M
Our MITPF coverage
Recent articles, reports, and earnings notes.
No research on MITPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate MITPF report →